MicroRNAs: Suggested role in pituitary adenoma pathogenesis

Journal of Endocrinological Investigation

Volumn 36, Issue 10, 2013, Pages 889-895

  Gadelha, M R ^a   Kasuki, L ^a   Denes J ^b   Trivellin, G ^b   Korbonits, M ^b  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

miRNA; Pathogenesis; Pituitary adenoma

Indexed keywords

MICRORNA; RNA BINDING PROTEIN; RNA POLYMERASE II;

3' UNTRANSLATED REGION; BASE PAIRING; BIOSYNTHESIS; HUMAN; HYPOPHYSIS ADENOMA; METASTASIS; MULTIPLE ENDOCRINE NEOPLASIA; NEOPLASM; NONHUMAN; OPEN READING FRAME; PATHOGENESIS; PROMOTER REGION; RNA BINDING; SHORT SURVEY;

ADENOMA; ANIMALS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; PITUITARY NEOPLASMS; PROGNOSIS;

EID: 84891681212     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.1007/BF03346759     Document Type: Short Survey

References (52)

1. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005, 120: 15-20.
2. Carthew RW, Sontheimer EJ. Origins and Mechanisms of miRNAs and siRNAs. Cell 2009, 136: 642-55.
3. Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993, 75: 843-54.
4. Taft RJ, Pang KC, Mercer TR, Dinger M, Mattick JS. Non-coding RNAs: regulators of disease. J Pathol 2010, 220: 126-39.
5. Fabian MR, Sonenberg N, Filipowicz W. Regulation of mRNA translation and stability by microRNAs. Annu Rev Biochem 2010, 79: 351-79.
6. Farazi TA, Spitzer JI, Morozov P, Tuschl T. miRNAs in human cancer. J Pathol 2011, 223: 102-15.
7. Monteys AM, Spengler RM, Wan J, et al. Structure and activity of putative intronic miRNA promoters. RNA 2010, 16: 495-505.
8. Yi R, Qin Y, Macara IG, Cullen BR. Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev 2003, 17: 3011-6.
9. Beilharz TH, Humphreys DT, Clancy JL, et al. microRNA-mediated messenger RNA deadenylation contributes to translational repression in mammalian cells. PLoS One 2009, 4: e6783.
10. Wang WX, Wilfred BR, Xie K, et al. Individual microRNAs (miRNAs) display distinct mRNA targeting "rules". RNA Biol 2010, 7: 373-80.
11. Rigoutsos I. New tricks for animal microRNAS: targeting of amino acid coding regions at conserved and nonconserved sites. Cancer Res 2009, 69: 3245-8.
12. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 2009, 136: 215-33.
13. Ye W, Lv Q, Wong CK, et al. The effect of central loops in miRNA:MRE duplexes on the efficiency of miRNA-mediated gene regulation. PLoS One 2008, 3: e1719.
14. Long D, Lee R, Williams P, Chan CY, Ambros V, Ding Y. Potent effect of target structure on microRNA function. Nat Struct Mol Biol 2007, 14: 287-94.
15. Sun G, Li H, Rossi JJ. Sequence context outside the target region influences the effectiveness of miR-223 target sites in the RhoB 3′UTR. Nucleic Acids Res 2010, 38: 239-52.
16. Kertesz M, Iovino N, Unnerstall U, Gaul U, Segal E. The role of site accessibility in microRNA target recognition. Nat Genet 2007, 39: 1278-84.
17. Kedde M, Strasser MJ, Boldajipour B, et al. RNA-binding protein Dnd1 inhibits microRNA access to target mRNA. Cell 2007, 131: 1273-86.
18. Iorio MV, Ferracin M, Liu CG, et al. MicroRNA gene expression deregulation in human breast cancer. Cancer Res 2005, 65: 7065-70.
19. Ciafre SA, Galardi S, Mangiola A, et al. Extensive modulation of a set of microRNAs in primary glioblastoma. Biochem Biophys Res Commun 2005, 334: 1351-8.
20. Xia XM, Jin WY, Shi RZ, Zhang YF, Chen J. Clinical significance and the correlation of expression between Let-7 and K-ras in non-small cell lung cancer. Oncol Lett 2010, 1: 1045-7.
21. Scheithauer BW, Kovacs K, Horvath E, et al. Pituitary blastoma. Acta Neuropathol 2008, 116: 657-66.
22. Wildi-Runge S, Bahubeshi A, Carret A, et al. New phenotype in the familial DICER1 tumor syndrome: pituitary blastoma presenting at age 9 months. Endocr Rev 2011, 32: P1-777.
23. Scheithauer BW, Horvath E, Abel TW, et al. Pituitary blastoma: a unique embryonal tumor. Pituitary 2012, 15: 365-73.
24. Herman V, Fagin J, Gonsky R, Kovacs K, Melmed S. Clonal origin of pituitary adenomas. J Clin Endocrinol Metab 1990, 71: 1427-33.
25. Chahal HS, Chapple JP, Frohman LA, Grossman AB, Korbonits M. Clinical, genetic and molecular characterization of patients with familial isolated pituitary adenomas (FIPA). Trends Endocrinol Metab 2010, 21: 419-27.
26. Georgitsi M. MEN-4 and other multiple endocrine neoplasias due to cyclin-dependent kinase inhibitors (p27(Kip1) and p18(INK4C)) mutations. Best Pract Res Clin Endocrinol Metab 2010, 24: 425-37.
27. Lemos MC, Thakker RV. Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene. Hum Mutat 2008, 29: 22-32.
28. Rostad S. Pituitary adenoma pathogenesis: an update. Curr Opin Endocrinol Diabetes Obes 2012, 19: 322-7.
29. Wang C, Su Z, Sanai N, et al. microRNA expression profile and differentially-expressed genes in prolactinomas following bromocriptine treatment. Oncol Rep 2012; 27: 1312-20.
30. Bottoni A, Piccin D, Tagliati F, Luchin A, Zatelli MC, degli Uberti EC. miR-15a and miR-16-1 down-regulation in pituitary adenomas. J Cell Physiol 2005, 204: 280-5.
31. Bottoni A, Zatelli MC, Ferracin M, et al. Identification of differentially expressed microRNAs by microarray: a possible role for microRNA genes in pituitary adenomas. J Cell Physiol 2007, 210: 370-7.
32. Mao ZG, He DS, Zhou J, et al. Differential expression of microRNAs in GH-secreting pituitary adenomas. Diagn Pathol 2010, 5: 79.
33. Amaral FC, Torres N, Saggioro F, et al. MicroRNAs differentially expressed in ACTH-secreting pituitary tumors. J Clin Endocrinol Metab 2009; 94: 320-3.
34. Butz H, Liko I, Czirjak S, et al. MicroRNA profile indicates downregulation of the TGFbeta pathway in sporadic non-functioning pituitary adenomas. Pituitary 2011, 14: 112-24.
35. Cheunsuchon P, Zhou Y, Zhang X, et al. Silencing of the imprinted DLK1-MEG3 locus in human clinically nonfunctioning pituitary adenomas. Am J Pathol 2011, 179: 2120-30.
36. Stilling G, Sun Z, Zhang S, et al. MicroRNA expression in ACTH-producing pituitary tumors: up-regulation of microRNA-122 and - 493 in pituitary carcinomas. Endocrine 2010, 38: 67-75.
37. Huang W, Li MD. Differential allelic expression of dopamine D1 receptor gene (DRD1) is modulated by microRNA miR-504. Biol Psychiatry 2009, 65: 702-5.
38. Tobon KE, Chang D, Kuzhikandathil EV. MicroRNA 142-3p mediates post-transcriptional regulation of D1 dopamine receptor expression. PLoS One 2012, 7: e49288.
39. Calin GA, Dumitru CD, Shimizu M, et al. Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 2002, 99: 15524-9.
40. Fusco A, Fedele M. Roles of HMGA proteins in cancer. Nat Rev Cancer 2007, 7: 899-910.
41. Fedele M, Battista S, Kenyon L, et al. Overexpression of the HMGA2 gene in transgenic mice leads to the onset of pituitary adenomas. Oncogene 2002, 21: 3190-8.
42. Qian ZR, Asa SL, Siomi H, et al. Overexpression of HMGA2 relates to reduction of the let-7 and its relationship to clinicopathological features in pituitary adenomas. Mod Pathol 2009, 22: 431-41.
43. Wang T, Zhang X, Obijuru L, et al. A micro-RNA signature associated with race, tumor size, and target gene activity in human uterine leiomyomas. Genes Chromosomes Cancer 2007, 46: 336-47.
44. Shell S, Park SM, Radjabi AR, et al. Let-7 expression defines two differentiation stages of cancer. Proc Natl Acad Sci U S A 2007, 104: 11400-5.
45. Park SM, Shell S, Radjabi AR, et al. Let-7 prevents early cancer progression by suppressing expression of the embryonic gene HMGA2. Cell Cycle 2007, 6: 2585-90.
46. Palmieri D, D'Angelo D, Valentino T, et al. Downregulation of HMGA-targeting microRNAs has a critical role in human pituitary tumorigenesis. Oncogene 2012, 31: 3857-65.
47. D'Angelo D, Palmieri D, Mussnich P, et al. Altered microRNA expression profile in human pituitary GH adenomas: down-regulation of miRNA targeting HMGA1, HMGA2, and E2F1. J Clin Endocrinol Metab 2012, 97: E1128-38.
48. Datto MB, Li Y, Panus JF, Howe DJ, Xiong Y, Wang XF. Transforming growth factor beta induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. Proc Natl Acad Sci U S A 1995, 92: 5545-9.
49. Butz H, Liko I, Czirjak S, et al. Down-regulation of Wee1 kinase by a specific subset of microRNA in human sporadic pituitary adenomas. J Clin Endocrinol Metab 2010, 95: E181-91.
50. Trivellin G, Butz H, Delhove J, et al. MicroRNA miR-107 is overexpressed in pituitary adenomas and in vitro inhibits the expression of aryl hydrocarbon receptor-interacting protein (AIP). Am J Physiol Endocrinol Metab 2012, 303: E708-19.
51. Palumbo T, Faucz FR, Azevedo M, Xekouki P, Iliopoulos D, Stratakis CA. Functional screen analysis reveals miR-26b and miR-128 as central regulators of pituitary somatomammotrophic tumor growth through activation of the PTEN-AKT pathway. Oncogene 2013, 32: 1651-9.
52. Luzi E, Marini F, Giusti F, Galli G, Cavalli L, Brandi ML. The negative feedback-loop between the oncomir Mir-24-1 and menin modulates the Men1 tumorigenesis by mimicking the "Knudson's second hit". PLoS One 2012; 7: e39767.